This systematic review (s=27) of oral ketamine for chronic cancer and non-cancer pain found that mean pain scores fell from 7.72/10 to 3.2/10 over 30 to 90 days, though only 5 studies had sufficient dosing consistency for quantitative analysis, with 35 mg/70kg three times daily identified as an effective regimen with an acceptable safety profile.
- Published
- Journal
- Journal of Pain Research
- Authors
- Winegarden, J., Brose, A., Storm, A., Mortensen, A., Carr, D.